Program

Scientific Program 2017

REGISTRATION PICK-UP:
Wednesday, January 11
| Noon - 5:00 PM
Thursday, January 12
| 6:30 AM - 5:00 PM
Friday, January 13
| 6:30 AM - 5:00 PM

Exhibit Floor:
Opens Thursday, January 12
| 9:00 AM

THURSDAY, JANUARY 12, 2017
Morning Scientific Session

7:00 - 7:10 AM

Welcome and Overview of the 22nd Annual AF Symposium

Jeremy Ruskin, MD

7:10 - 9:40 AM

Mechanisms and Genetics of Atrial Fibrillation

All lectures 15 minutes; Q&A during panel discussion

Moderators: Jose Jalife, MD & Stanley Nattel, MD

New Insights Into the Mechanistic Links Between Inflammation, Oxidative Stress and AF

David Van Wagoner, PhD

AF Is Associated With Fibrotic Remodeling of Subepicardial Adipose Tissue in Sheep and Human Atria

Jose Jalife, MD

Reentrant Drivers Anchoring to Structural Heterogeneities: A Major Pathophysiological Mechanism of Human Persistent AF

Natalia Trayanova, PhD

Hypercoagulable State During AF Promotes Atrial Fibrosis and AF

Ulrich Schotten, MD, PhD

Is Atrial Fibrosis Reversible?
Future Directions in Anti-Fibrotic Therapy

Stanley Nattel, MD

Atrial Myopathy and Fibrosis: Lessons from 10 Years of MR Imaging

Nassir Marrouche, MD

AF Genetics and Genome Sequencing in 2017: What Have We Learned?

Patrick Ellinor, MD, PhD

Prevention of AF: A Basic Scientist’s Perspective

David Van Wagoner, PhD

Panel and Audience Q&A and Discussion
30 minutes (All Faculty)

Moderator: Jose Jalife, MD

9:40 - 10:10 AM

Break and Exhibits

10:10 - 11:45 AM

Screening for Atrial Fibrillation - Rationale, Results and Clinical Impact

All lectures 15 minutes; q&a during panel discussion

Moderator: Emelia Benjamin, MD, ScM

General Considerations in Screening Programs for Atrial Fibrillation

Daniel Singer, MD

Progress and Worldwide Experience With AF Screening for AF in 2017

John Camm, MD

Update on the Epidemiology of AF and Significance of Transient AF

Emelia Benjamin, MD

Device Detected AF: What is the Stroke Risk and When Should Anticoagulants Be Used?

Daniel Singer, MD

Advantages and Limitations of Current Technologies for AF Detection

Suneet Mittal, MD

Panel and Audience Q&A and Discussion
20 minutes (All Faculty)

Moderator: Emelia Benjamin, MD, ScM

11:45 AM - 12:30 PM

Clinical Trials, Guidelines and Regulatory Issues in AF Ablation

All lectures 15 minutes; no q&a

Moderator: Hugh Calkins, MD

Clinical Trials on New Technologies for AF Ablation

Hugh Calkins, MD

2017 ESC AF Guidelines and Comparison of AF Guidelines Across the World

John Camm, MD

Evidence Generation in AF Ablation Device Studies: Challenges and Opportunities

Jun Dong, MD, PhD

12:30 - 2:00 PM

Lunch and Exhibits

THURSDAY, JANUARY 12, 2017
Afternoon Scientific Session

2:00 - 2:30 PM

Clinical Trials and Regulatory Issues in LAA Closure

All lectures 15 minutes; no q&a

Moderator: Hugh Calkins, MD

LAA Closure: The Munich Consensus Document on Definitions, Endpoints, and Data Collection Requirements for Clinical Studies

Dhanunjaya Lakkireddy, MD

Clinical Trials of Left Atrial Appendage Occlusion Devices: Update From the FDA

Andrew Farb, MD

2:30 - 4:00 PM

Challenging Cases in AF Management I:
Antiarrhythmic Drugs, Anticoagulation,
and Clinical Decision Making

Panel and Audience Discussion (10 minutes per case)

Moderator: Eric Prystowsky, MD

Panel: Peter Kowey, MD, Suneet Mittal, MD,
Eric Prystowsky, MD, and Jeremy Ruskin, MD

4:00 - 4:30 PM

Break and Exhibits

4:30 - 6:00 PM

Challenging Cases in AF Management II: Catheter Ablation for AF and Left Atrial Appendage Closure

Panel and Audience Discussion (10 minutes per case)

Moderator: David Keane, MD, PhD

Panel: Shih-Ann Chen, MD, Isabel Deisenhofer, MD,
Pierre Jais, MD, Hans Kottkamp, MD, Andrea Natale, MD and Vivek Reddy, MD

6:00 PM

Adjourn

FRIDAY, JANUARY 13, 2017
Morning Scientific Session

7:00 - 10:30 AM

Case Transmissions: Advances in Catheter Ablation for AF and Left Atrial Appendage Closure

Moderators: Moussa Mansour, MD and
Jeremy Ruskin, MD

Panel: Pierre Jais, MD, Francis Marchlinski, MD,
Andrea Natale, MD, Douglas Packer, MD,
Vivek Reddy, MD and David Wilber, MD

Na Homolce Hospital, Prague, Czech Republic

Peter Neuzil, MD, Jan Petru, MD and Jan Skoda, MD

University of Milan Centro Cardiologico Monzino, Milan, Italy

Claudio Tondo, MD, PhD, Antonio Dello Russo, MD, PhD, Gaetano Fassini, MD and Massimo Moltrasio, MD, PhD

Massachusetts General Hospital, Boston, MA

Kevin Heist, MD, PhD, Conor Barrett, MD and
Moussa Mansour, MD

Loyola University Medical Center, Chicago, IL

David Wilber, MD and Smit Vasaiwala, MD

Texas Cardiac Arrhythmia Institute, Austin, Texas

Rodney Horton, MD, Amin Al-Ahmad, MD,
David Burkhardt, MD and Andrea Natale, MD

Intermountain Medical Center, Murray, UT

T. Jared Bunch, MD and John Day, MD

10:30 - 11:00 AM

Break and Exhibits

11:00 AM - 1:15 PM

Stroke Prevention in Atrial Fibrillation

Moderators: Elaine Hylek, MD, MPH and
Daniel Singer, MD

All lectures 15 minutes; q&a during panel discussion

Real World Use of Novel Anticoagulants in AF: Insights and Limitations

John Camm, MD

PRN NOACs After “Successful” Catheter Ablation for AF

Francis Marchlinski, MD

Reversal Agents for Direct Thrombin and Factor XA Inhibitors

Elaine Hylek, MD, MPH

AF and Acute Coronary Syndromes: Trial Results and Clinical Recommendations

Peter Kowey, MD

Stroke Risk After Left Atrial Appendage Isolation

Luigi Di Biase, MD, PhD

Mechanical Left Atrial Appendage Closure:
Patient Selection, Outcomes, Safety

Dhanunjaya Lakkireddy, MD

Hospital Admissions for AF in the NOAC Era: Annual Trends, Economic Impact and New Strategies

Jeremy Ruskin, MD

Panel and Audience Q&A and Discussion 30 minutes (All Faculty)

Moderators: Elaine Hylek, MD, MPH and
Daniel Singer, MD

1:15 - 2:45 PM

Lunch and Exhibits

FRIDAY, JANUARY 13, 2017
Afternoon Scientific Session

2:45 - 4:30 PM

Mapping and Ablation of Atrial Fibrillation I:

Lesion Formation and Durability in AF Ablation

Moderators: Shih-Ann Chen, MD and Douglas Packer, MD

All lectures 15 minutes; q&a during panel discussion

Combining Input from Force, Power, Duration, Temperature, and Catheter Orientation for Accurate Lesion Assessment

Moussa Mansour, MD

Recent Advances in Energy Sources and Lesion Assessment Tools

Vivek Reddy, MD

Real-Time MRI for AF Ablation: Cryoballoon and RF

Nassir Marrouche, MD

Advances in Balloon Technologies for AF Ablation

Karl-Heinz Kuck, MD

New Generation Noninvasive Extracorporeal Ablation for AF

Douglas Packer, MD

Panel and Audience Q&A and Discussion
30 minutes (All Faculty)

Moderator: Douglas Packer, MD

4:45 - 5:20 PM

Late Breaking Clinical Trials and First Report Investigations

Moderator: Jeremy Ruskin, MD

Presentations 15 minutes & 5 minutes Q&A

4:45-5:00 PM

Initial Evaluation of a Multi-electrode Radiofrequency
Ablation Balloon Catheter System in Patients
with Symptomatic Paroxysmal Atrial Fibrillation

Matthew G. Daly, MB, ChB

5:05-5:20 PM

AMPLATZER Amulet Observational Study of Left Atrial Appendage Occlusion:
Use of lntracardiac and Transophageal Echocardiography

Boris Schmidt, MD

5:20 PM

Adjourn

 

SATURDAY, JANUARY 14, 2017
Morning Scientific Session

7:00 - 9:00 AM

Mapping and Ablation of Atrial Fibrillation II:
Beyond PVI Mechanistic Insights and Impact
on Ablation Strategies

Moderator: David Keane, MD, PhD

All lectures 15 minutes; q&a during panel discussion

Can Advanced Mapping Algorithms Be Rigorously Validated? - An FDA Scientist’s Viewpoint

Richard Gray, PhD

AF Mapping: Principles, Current Techniques and Limitations - Phase, Activation, and Optical Mapping for AF: Which One and When?

Sanjiv Narayan, MD, PhD

Long-Term Outcomes of FIRM-Guided Ablation: Incidence, Mechanisms & Predictors of Failure

David Wilber, MD

Single Center Experience with Catheter Ablation for Non-Paroxysmal AF

Andrea Natale, MD

Targeting Reentrant Drivers: Ablation Techniques and Endpoints

Michel Haissaguerre, MD

Characterization of Focal Activation in Patients with Persistent and Longstanding Persistent AF from Intraoperative High-Density Mapping

Albert Waldo, MD

“Rotors” Detected by Phase Analysis of Filtered EGMs Identify Conduction Block and Not Rotating Wavefronts

Ulrich Schotten, MD, PhD

Long-Term Outcome of CFAE Guided Ablation of Longstanding Persistent AF: Why Our Results Differ from STAR AF II?

Young-Hoon Kim, MD, PhD

9:00 - 9:30 AM

Break and Exhibits

9:30 - 11:30 AM

Mapping and Ablation of Atrial Fibrillation II:
Beyond PVI Mechanistic Insights and Impact
on Ablation Strategies

Moderator: Francis Marchlinski, MD

All lectures 15 minutes; q&a during panel discussion

New Findings with Ablation of Fibrotic Areas in Persistent AF

Hans Kottkamp, MD

Role of Non-Pulmonary Vein Triggers in AF Ablation

Francis Marchlinski, MD

Is Trigger Ablation Necessary to Abolish AF or Is PVI Alone As Effective?

Karl-Heinz Kuck, MD

Hybrid Alternatives for the Treatment of Persistent AF

Randall Lee, MD

Epicardial Mapping and Ablation in Repeat Ablation for Persistent AF: Preliminary Results of a Prospective Randomized Controlled Trial

Young-Hoon Kim, MD, PhD

New Observations on Post-Ablation Atrial Tachycardia

Pierre Jais, MD

Panel and Audience Q&A and Discussion
30 Minutes (All Faculty)

Moderators: Francis Marchlinski, MD

11:30 AM - 1:00 PM

Lunch and Exhibits

SATURDAY, JANUARY 14, 2017
Afternoon Scientific Session

1:00 - 3:30 PM

Mapping and Catheter Ablation for
Atrial Fibrillation III:
Outcomes, Safety, and Economic Impact

Moderator: John Day, MD

Predictive Models of AF Ablation Outcomes from Pre-Ablation Clinical Data

Roger Winkle, MD

Sleep Apnea and Non-PV Triggers: Mechanisms and Impact on Outcomes of AF Ablation

Elad Anter, MD

Impact of Age and BMI on Long-Term Outcomes of AF Ablation

John Day, MD

Predictors of Intra-Procedural Termination and Outcome of PVI Plus EGM Guided Substrate Modification for Persistent AF

Isabel Deisenhofer, MD

Esophageal Injury in AF Ablation and Complications Related to Post-Ablation Endoscopy

Thomas Deneke, MD

Serious Long-Term Consequences of Missed PV Stenosis After AF Ablation

Douglas Packer, MD

Safety and Economic Impact of Force Sensing in AF Ablation

Moussa Mansour, MD

LAA Closure Devices: Safety and Economic Impact

Vivek Reddy, MD

Panel and Audience Q&A and Discussion
30 minutes (All Faculty)

Moderator: John Day, MD

3:30 PM

Adjourn

CME Certification Requests

AF Symposium 
Information Regarding CME Certificate Requests
 
If you wish to receive acknowledgment for completing this activity, please complete the evaluation on www.cmeuniversity.com.  On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 11472.  Upon registering and successfully completing activity evaluation, your certificate will be made available immediately.
 
 
 
*Please note for ANCC credit, you must complete an evaluation for each day of the symposium.

Newsletter Archive

Faculty Presentation Submission Portal

 

Course Directors

Jeremy N. Ruskin, MD
Moussa Mansour, MD

Vivek Reddy, MD

David Keane, MD, PhD
Pierre Jais, MD

 

REGISTRATION NOW OPEN

 

January 11-13, 2018

Hyatt Regency Orlando,
Orlando, FL